Enervit Logo

Enervit

ENV | XMIL

Overview

Corporate Details

ISIN(s):
IT0004356751
LEI:
8156002B06C3A4C0F436
Country:
Italy
Address:
VIALE PAPA ACHILLE, 30, 20149 MILANO
Sector:
Health Care
Industry:
Pharmaceuticals

Description

Positive nutrition is part of our DNA. It has always guided our advancements in field research and deepened our passion for innovation. It drives us to study the lifestyles and eating habits of the populations that have learned to live better and longer. It allows us to anticipate the nutrition of the future. It leads us to formulate and produce ideal nutrition and supplement solutions for those who practice sports, those who are health-conscious and those who want to stay in shape. All this with a specific objective: to help everyone improve the quality of their life. For over 40 years, a passion for sports nutrition has driven our scientific research. Day after day, thanks to this unique experience we invent, test, develop and produce high-quality functional foods and innovative supplements. Ours is a fully in-house approach to satisfying the nutritional needs of those who practice sports, those who are health-conscious and those who want to stay in shape.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-05-14 14:19
Earnings Release
CS Dati Trimestrali Vendite al 31 marzo 2025
Italian 321.3 KB
2025-04-28 13:01
Notice of Dividend Amount
AVVISO pagamento Dividendo Esercizio 2024
Italian 146.3 KB
2025-04-28 12:59
AGM Report
Rendiconto Sintetico delle Votazioni
Italian 219.2 KB
2025-04-28 12:57
AGM Report
CS post Assemblea Ordinaria del 28.04.2025
Italian 273.4 KB
2025-04-07 11:25
Report Publication Announcement
Avviso su quot Deposito Rel Fin Annuale
Italian 582.8 KB
2025-04-07 11:23
Report Publication Announcement
CS - Deposito Relazione Finanziaria Annuale
Italian 164.3 KB
2025-04-07 11:07
Corporate Governance Report
Relazione sul Governo Societario Assemblea 2025 Esercizio 2024
Italian 991.9 KB
2025-04-07 11:05
Remuneration Report
Relazione sulla Remunerazione
Italian 710.3 KB
2025-03-19 14:18
Proxy Solicitation & Information Statements
Delega RD Undecies
Italian 437.0 KB
2025-03-19 14:17
Proxy Solicitation & Information Statements
Delega a RD Novies
Italian 387.6 KB
2025-03-19 14:12
General Meeting Notice
ESTRATTO avviso di convocazione Assemblea Ordinaria
Italian 157.1 KB
2025-03-19 14:10
AGM Report
Relazione illustrativa sulle materie all'ordine del giorno
Italian 9.8 MB
2025-03-19 14:08
Declaration of Voting Results & Voting Rights Announcements
AVVISO di convocazione Assemblea ordinaria
Italian 204.5 KB
2025-03-19 14:06
Earnings Release
CS - CDA approva il progetto di bilancio
Italian 491.6 KB
2025-01-07 17:20
General Meeting Notice
verbale assemblea straordinaria 16.12.2024
Italian 2.4 MB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ABIVAX Logo ABIVAX France ABVX
Addex Therapeutics Ltd Logo Addex Therapeutics Ltd Switzerland ADXN
AegirBio AB Logo AegirBio AB Sweden AEGIR
AGRONOMICS LIMITED Logo AGRONOMICS LIMITED Isle of Man ANIC
AIREA PLC Logo AIREA PLC United Kingdom AIEA
Alkaloid AD Logo Alkaloid AD North Macedonia ALK
Alma Yesodot Ltd. Israel KVSR
Amphastar Pharmaceuticals Inc. Logo Amphastar Pharmaceuticals Inc. United States of America AMPH
Ananda Pharma Plc United Kingdom N/A
Antibiotice S.A. Logo Antibiotice S.A. Romania ATB